# Cholestyramine

NDC: 33342-319
Generic name: Cholestyramine
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20241121

FDA application: ANDA209109

## Active ingredients

- CHOLESTYRAMINE: 4 g/5.7g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-319"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-319
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c41529f1-16d2-4ca3-91eb-f809571f5ae3